This inventor holds 1 USPTO granted patent. Top assignees: Assistance Publique - Hopitaux De Paris (Aphp), National Institute of Health and Medical Research, Université De Paris. Active years: 2026.
Company Filing History:
1 out of 77 
1 out of 1,853 
1 out of 68 
Years Active: 2026
Title: Edith Aberdam: Innovator in Wound Healing Technologies
Introduction
Edith Aberdam is a prominent inventor based in Paris, France. She has made significant contributions to the field of wound healing, particularly for individuals suffering from ectodermal dysplasias. Her innovative approaches have the potential to improve the quality of life for many patients.
Latest Patents
Edith Aberdam holds a patent for "Methods and compositions for promoting wound healing in a subject suffering from ectodermal dysplasias." This invention involves a method for promoting wound healing by administering a therapeutically effective amount of a compound that restores the activity of p63. The research demonstrated that patient keratinocytes treated with compounds such as STIMA-1 and PRIMA-1Met showed significant differentiation compared to untreated cells. Furthermore, topical application of PRIMA-1Met on a young patient resulted in notable improvements in her hand, healing severe skin erosions.
Career Highlights
Throughout her career, Edith has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. Her work has been pivotal in advancing the understanding and treatment of ectodermal dysplasias.
Collaborations
Edith has collaborated with notable colleagues, including Daniel Aberdam and Smail Hadj-Rabia, contributing to the success of her research and innovations.
Conclusion
Edith Aberdam's work in the field of wound healing represents a significant advancement for patients with ectodermal dysplasias. Her innovative methods and dedication to research continue to inspire progress in medical science.